2022 ESMO Congress
The 2022 European Society for Medical Oncology (ESMO) Congress, held September 9-13 in Paris, France, featured a range of topics on hematologic malignancies, including chimeric antigen receptor (CAR) T-cell therapies in myelodysplastic syndromes (MDS), the burden of infection in patients with myeloma and secondary immunodeficiencies, and more.
Advertisement
Advertisement
CART-ddBCMA demonstrated a 100% overall response rate in patients with relapsed/refractory multiple myeloma.
Patients with both multiple myeloma (MM) and secondary immunodeficiencies (SID) face...
The results of the trial were presented during the 2022 ESMO Congress by Chunkang Chang, MD, PhD.
Blood Cancers Today delivers the latest news, education, and information relevant to hematologic oncology patients and practices.
Sign up to receive Blood Cancers Today eNewsletters:
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.